Ambuja Cements (AMBUJACEM) — Financial Results

Ambuja Cements reported ₹9,329 crores revenue for Q3 FY25, up 32% YoY, driven by volume growth and cost initiatives. EBITDA margin stood at 18.4%, with EBITDA per ton at ₹1,038. Cash reserves reached ₹8,755 crores, while operational costs fell to ₹4,618/ton due to green energy adoption and logistics optimization. The company commissioned a 200 MW solar project and acquired 631 Mt of limestone reserves, supporting its target of 140 million tons capacity by FY28.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this financial results affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 4 February 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 4 February 2025

SBIN State Bank of India Financial Results SRF SRF Limited Financial Results TATAPOWER Tata Power Company Limited Financial Results TATAPOWER Tata Power Company Limited Financial Results TATAPOWER Tata Power Company Limited Financial Results RECLTD REC Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.